BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30305100)

  • 21. Tunneling nanotube-transmitted mechanical signal and its cellular response.
    Wang Y; Han X; Deng L; Wang X
    Biochem Biophys Res Commun; 2024 Jan; 693():149368. PubMed ID: 38091838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
    D'Aloia A; Berruti G; Costa B; Schiller C; Ambrosini R; Pastori V; Martegani E; Ceriani M
    Exp Cell Res; 2018 Jan; 362(2):349-361. PubMed ID: 29208460
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Lou E
    Front Oncol; 2020; 10():559548. PubMed ID: 33324545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional analysis of tunneling nanotubes (TnTs) using gCW STED and gconfocal approaches.
    Bénard M; Schapman D; Lebon A; Monterroso B; Bellenger M; Le Foll F; Pasquier J; Vaudry H; Vaudry D; Galas L
    Biol Cell; 2015 Nov; 107(11):419-25. PubMed ID: 26094971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma.
    Sarkari A; Korenfeld S; Deniz K; Ladner K; Wong P; Padmanabhan S; Vogel RI; Sherer LA; Courtemanche N; Steer C; Wainer-Katsir K; Lou E
    Elife; 2023 Nov; 12():. PubMed ID: 37955637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).
    Omsland M; Bruserud Ø; Gjertsen BT; Andresen V
    Oncotarget; 2017 Jan; 8(5):7946-7963. PubMed ID: 27974700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myo10 is a key regulator of TNT formation in neuronal cells.
    Gousset K; Marzo L; Commere PH; Zurzolo C
    J Cell Sci; 2013 Oct; 126(Pt 19):4424-35. PubMed ID: 23886947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes.
    Thayanithy V; Dickson EL; Steer C; Subramanian S; Lou E
    Transl Res; 2014 Nov; 164(5):359-65. PubMed ID: 24929208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of long-distance cell-to-cell communication and autophagosome transfer in squamous cell carcinoma via tunneling nanotubes.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Enciso E; García-Moreno I; Chiara JL; Suarez C; Chiara MD
    Oncotarget; 2017 Mar; 8(13):20939-20960. PubMed ID: 28423494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tunneling nanotubes: emerging view of their molecular components and formation mechanisms.
    Kimura S; Hase K; Ohno H
    Exp Cell Res; 2012 Aug; 318(14):1699-706. PubMed ID: 22652450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GFAP serves as a structural element of tunneling nanotubes between glioblastoma cells and could play a role in the intercellular transfer of mitochondria.
    Simone L; Capobianco DL; Di Palma F; Binda E; Legnani FG; Vescovi AL; Svelto M; Pisani F
    Front Cell Dev Biol; 2023; 11():1221671. PubMed ID: 37886397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Characterization of Tunneling Nanotubes for Intercellular Trafficking.
    Abounit S; Delage E; Zurzolo C
    Curr Protoc Cell Biol; 2015 Jun; 67():12.10.1-12.10.21. PubMed ID: 26061240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of tolytoxin on tunneling nanotube formation and function.
    Dilsizoglu Senol A; Pepe A; Grudina C; Sassoon N; Reiko U; Bousset L; Melki R; Piel J; Gugger M; Zurzolo C
    Sci Rep; 2019 Apr; 9(1):5741. PubMed ID: 30952909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rab35 and its effectors promote formation of tunneling nanotubes in neuronal cells.
    Bhat S; Ljubojevic N; Zhu S; Fukuda M; Echard A; Zurzolo C
    Sci Rep; 2020 Oct; 10(1):16803. PubMed ID: 33033331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease.
    Zhang S; Kazanietz MG; Cooke M
    Am J Physiol Cell Physiol; 2020 Nov; 319(5):C877-C884. PubMed ID: 32845720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells.
    Bukoreshtliev NV; Wang X; Hodneland E; Gurke S; Barroso JF; Gerdes HH
    FEBS Lett; 2009 May; 583(9):1481-8. PubMed ID: 19345217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tunneling nanotubes: Diversity in morphology and structure.
    Austefjord MW; Gerdes HH; Wang X
    Commun Integr Biol; 2014 Jan; 7(1):e27934. PubMed ID: 24778759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.